Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semapimod Long-term Study in Crohn's Disease
NCT00740103Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2002
- Primary completion
- Jul 2004
- Modality
- Classical Binding Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of semapimod in Crohn's disease, sponsored by Ferring Pharmaceuticals. Started Dec 2002; status: completed.
02
Drugs
semapimod
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00740103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740103.